Pharmacological inhibition of SK‐channels with AP14145 prevents atrial arrhythmogenic changes in a porcine model for obstructive respiratory events

Obstructive sleep apnea (OSA) creates a complex substrate for atrial fibrillation (AF), which is refractory to many clinically available pharmacological interventions. We investigated atrial antiarrhythmogenic properties and ventricular electrophysiological safety of small‐conductance Ca2+‐activated K+ (SK)‐channel inhibition in a porcine model for obstructive respiratory events.

[1]  M. A. Skarsfeldt,et al.  Small conductance calcium activated K+ channel inhibitor decreases stretch induced vulnerability to atrial fibrillation , 2021, International journal of cardiology. Heart & vasculature.

[2]  Christopher X. Wong,et al.  Prevalence and Assessment of Sleep-Disordered Breathing in Patients with Atrial Fibrillation:A Systematic Review and Meta-Analysis. , 2021, The Canadian journal of cardiology.

[3]  D. Hillman,et al.  The Social And Economic Cost Of Sleep Disorders. , 2021, Sleep.

[4]  P. Kohl,et al.  Small Conductance Ca2 +-Activated K+ (SK) Channel mRNA Expression in Human Atrial and Ventricular Tissue: Comparison Between Donor, Atrial Fibrillation and Heart Failure Tissue , 2021, Frontiers in Physiology.

[5]  S. Sattler,et al.  Arrhythmogenic mechanisms of acute obstructive respiratory events in a porcine model of drug-induced Long-QT. , 2021, Heart rhythm.

[6]  P. Sanders,et al.  Sleep apnoea has a dose-dependent effect on atrial remodelling in paroxysmal but not persistent atrial fibrillation: a high-density mapping study. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  M. A. Kobat,et al.  Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on Antiarrhythmic-Drug Therapy , 2020, Cardiology research.

[8]  P. Most,et al.  HDAC2-dependent remodeling of KCa2.2 (KCNN2) and KCa2.3 (KCNN3) K+ channels in atrial fibrillation with concomitant heart failure. , 2020, Life sciences.

[9]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[10]  M. Ward,et al.  Stretch modulation of cardiac contractility: importance of myocyte calcium during the slow force response , 2020, Biophysical Reviews.

[11]  L. Maier,et al.  Enhanced CaMKII-Dependent Late INa Induces Atrial Proarrhythmic Activity in Patients With Sleep-Disordered Breathing , 2020, Circulation research.

[12]  Sanjay R. Patel,et al.  Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. , 2019, The Lancet. Respiratory medicine.

[13]  R. Mahajan,et al.  Variability of Sleep Apnea Severity and Risk of Atrial Fibrillation: The VARIOSA-AF Study. , 2019, JACC. Clinical electrophysiology.

[14]  T. Anzai,et al.  Arrhythmogenic &bgr;‐adrenergic signaling in cardiac hypertrophy: The role of small‐conductance calcium‐activated potassium channels via activation of CaMKII , 2019, European journal of pharmacology.

[15]  P. de Chazal,et al.  Prediction in obstructive sleep apnoea: diagnosis, comorbidity risk, and treatment outcomes , 2018, Expert review of respiratory medicine.

[16]  J. Svendsen,et al.  Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca2+-Activated K+ Channels in Pigs , 2017, Circulation. Arrhythmia and electrophysiology.

[17]  M. Böhm,et al.  Low‐Level But Not High‐Level Baroreceptor Stimulation Inhibits Atrial Fibrillation in a Pig Model of Sleep Apnea , 2016, Cardiovascular Electrophysiology.

[18]  Po-Cheng Chang,et al.  SK channels and ventricular arrhythmias in heart failure. , 2015, Trends in cardiovascular medicine.

[19]  T. Jespersen,et al.  Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium , 2015, Journal of cardiovascular pharmacology.

[20]  Jean-Claude Tardif,et al.  Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. , 2014, Journal of the American College of Cardiology.

[21]  M. Böhm,et al.  Obstructive Sleep Apnea and Atrial Arrhythmogenesis , 2014, Current cardiology reviews.

[22]  P. Binkley,et al.  Calcium-Activated Potassium Current Modulates Ventricular Repolarization in Chronic Heart Failure , 2014, PloS one.

[23]  Changsheng Ma,et al.  Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  Lei Yuan,et al.  Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria. , 2014, Cardiovascular research.

[25]  L. Maier,et al.  Tubulin polymerization disrupts cardiac β-adrenergic regulation of late INa. , 2014, Cardiovascular research.

[26]  S. Nattel,et al.  Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog , 2014, Circulation.

[27]  U. Schotten,et al.  Effect of Renal Denervation on Neurohumoral Activation Triggering Atrial Fibrillation in Obstructive Sleep Apnea , 2013, Hypertension.

[28]  D. Roden,et al.  Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. , 2012, The American journal of cardiology.

[29]  U. Schotten,et al.  Renal Sympathetic Denervation Suppresses Postapneic Blood Pressure Rises and Atrial Fibrillation in a Model for Sleep Apnea , 2012, Hypertension.

[30]  U. Schotten,et al.  Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea. , 2011, Heart rhythm.

[31]  U. Schotten,et al.  Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. , 2011, Heart rhythm.

[32]  S. Chugh,et al.  Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. , 2011, The American journal of cardiology.

[33]  D. Bers,et al.  Reactive Oxygen Species–Activated Ca/Calmodulin Kinase II&dgr; Is Required for Late INa Augmentation Leading to Cellular Na and Ca Overload , 2011, Circulation research.

[34]  V. Regitz-Zagrosek,et al.  Differential Cardiac Remodeling in Preload Versus Afterload , 2010, Circulation.

[35]  Ling Lu,et al.  Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. , 2005, American journal of physiology. Heart and circulatory physiology.

[36]  M. Stocker.  Ca2+-activated K+ channels: molecular determinants and function of the SK family , 2004, Nature Reviews Neuroscience.

[37]  Yi Zhang,et al.  Molecular Identification and Functional Roles of a Ca2+-activated K+ Channel in Human and Mouse Hearts* , 2003, Journal of Biological Chemistry.

[38]  M. Allessie,et al.  Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. , 1997, Circulation.

[39]  C W Whitney,et al.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. , 2001, American journal of respiratory and critical care medicine.